跳至主要内容
临床试验/NCT07718373
NCT07718373尚未招募不适用

Early Postoperative L-arginine and Acute Kidney Injury After Cardiac Surgery: a Target Trial Emulation

Xijing Hospital0 个研究点目标入组 5,000 人开始时间: 2026年7月20日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
5,000
主要终点
Acute kidney injury

研究概览

简要总结

Acute kidney injury (AKI) is common after cardiac surgery, yet effective protective strategies remain limited. L-arginine is the substrate for endogenous nitric oxide (NO) synthesis and may improve renal perfusion and endothelial function. investigators emulated a target trial to evaluate whether early perioperative L-arginine was associated with a lower risk of AKI after cardiac surgery.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •·adults admitted to the ICU after CPB-assisted cardiac surgery

排除标准

  • •congenital heart disease,
  • •surgery requiring deep hypothermic circulatory arrest,
  • •a preoperative baseline estimated glomerular filtration rate (eGFR) below 30 mL/min/1.73 m²,
  • •AKI already present prior to ICU admission

研究组 & 干预措施

No L-arginine

No L-arginine therapy within 3 postoperative days

L-arginine

Initiation of L-arginine within 3 postoperative days

干预措施: L-arginine (Drug)

结局指标

主要结局

Acute kidney injury

时间窗: within 7 postoperative days

defined by KDIGO criteria

次要结局

  • 7-day mortality.(7 day)

研究者

发起方
Xijing Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Chong Lei, MD & phD

Principal investigator, Head of Anesthesia Clinical Research Center, Xijing Hospital

Xijing Hospital

相似试验